SCM
BIVV

Stevens Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Stevens Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,635
Closed -$250K – 1110
2017
Q4 		$250K Sell
4,635
-71,037
-94% -$3.89M 0.01% 698
2017
Q3 		$4.32M Buy
+75,672
New +$4.43M 0.16% 176

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Stevens Capital Management's BIVV Position: Q1 2018 in Review

Stevens Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 4,635 shares — an estimated $250K sold.

Stevens Capital Management first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $4.32M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Stevens Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Stevens Capital Management sold 4,635 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $250K.
  • Stevens Capital Management first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Stevens Capital Management's Bioverativ Inc. Common Stock position peaked at $4.32M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Stevens Capital Management's 13F filing for Q1 2018, filed 8 May 2018.